Catalyst Biosciences Inc at Raymond James Human Health Innovation Conference (Virtual) Transcript
Hello, everyone. My name is Timur Ivannikov and I am a Biotech Analyst at Raymond James. Today, we are pleased to host senior management team of Catalyst Biosciences at our annual Human Health Innovation Conference.
Today, we are hosting Nassim Usman, President and CEO of Catalyst; Howard Levy, Chief Medical Officer; and Chief Financial Officer, Clinton Musil; and SVP Translational Research, Grant Blouse. For everyone on the line, thank you for joining us today, and feel free to submit questions virtually. Nassim, I will hand it over to you for an overview of the Company before we get into the Q&A portion.
Thank you, Timur, and thank you all who are attending today. So good morning. Today, I will be making forward-looking statements during the presentation and during the Q&A.
So what is Catalyst Biosciences? We are the protease medicines company. And what we do is harness the catalytic power of proteases.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |